Placing ProLivRx in treatment sequence versus TMS

We interview Linda Carpenter, lead investigator on the new FDA approved device for difficult-to-treat depression.

CME: Take the CME Post-Test for this Episode

Published On: 01/19/2026

Duration: 20 minutes, 49 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.